Holger J. Schünemann

Statistics and Probability · 2004–2020

A researcher in the Science corpus: 40 papers; trusts 8 researchers and is trusted by 16 researchers here, as inferred from the citation graph.

Subfields

Whom Holger J. Schünemann trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Guyatt
  2. Andrew D. Oxman
  3. Regina Kunz
  4. Julian P. T. Higgins

Who trusts Holger J. Schünemann overall

  1. M. Samuel
  2. D. Dowell

Papers from Holger J. Schünemann's perspective

Ordered by how strongly the researchers Holger J. Schünemann trusts endorse each paper. Same corpus, a different order for every researcher.

  1. GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
  2. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. (Journal of Clinical Epidemiology)
  3. When are randomised trials unnecessary? Picking signal from noise (British medical journal)
  4. Selective publication of antidepressant trials and its influence on apparent efficacy. (New England Journal of Medicine)
  5. The safety of statins in clinical practice. (The Lancet)
  6. Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin (Diabetes Care)
  7. Pharmaceutical industry sponsorship and research outcome and quality: systematic review (British medical journal)
  8. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study (British medical journal)
  9. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. (Journal of the American Medical Association (JAMA))
  10. Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications (British medical journal)

Their papers